Review Frontiers in immunology · 2026 Research progress on intestinal probiotics-mediated protection of the intestinal mucosal barrier in ulcerative colitis. Ma G, Deng S Akkermansia muciniphila PubMed ↗
Randomized trial mSystems · 2026 Sialidase inhibitor modulates gut microbiota and enhances mucosal protection in the treatment of ulcerative colitis. Zhao Y, Chen L, Li C, et al. Akkermansia muciniphila PubMed ↗
Observational The oncologist · 2025 Machine learning identifies a distinct microbiota signature in immune checkpoint inhibitor colitis compared with inflammatory bowel disease. Barberio B, Patuzzi I, Bertin L, et al. Bifidobacterium longum PubMed ↗
Review Molecular biology reports · 2025 The gut immune axis in ulcerative colitis: insights from microbiome research. Wasim R Escherichia coliFaecalibacterium prausnitzii PubMed ↗
Observational Gastroenterology · 2025 Structural Variations in Ulcerative Colitis-associated Escherichia coli Reduce Fructose Utilization and Aggravate Inflammation Under High-Fructose Diet. Wu X, Li Y, Li P, et al. Escherichia coli PubMed ↗
Observational Nature communications · 2024 Multi-biome analysis identifies distinct gut microbial signatures and their crosstalk in ulcerative colitis and Crohn's disease. Akiyama S, Nishijima S, Kojima Y, et al. Enterococcus faeciumEscherichia coli PubMed ↗
Randomized trial Journal of Crohn's & colitis · 2024 Gut Microbial Species and Endotypes Associate with Remission in Ulcerative Colitis Patients Treated with Anti-TNF or Anti-integrin Therapy. Tamburini FB, Tripathi A, Gold MP, et al. Faecalibacterium prausnitziiFlavonifractor plautii PubMed ↗
Meta-analysis Clinical gastroenterology and hepatology · 2024 Gut Microbiota Features in Relation to Fecal Microbiota Transplantation Outcome in Ulcerative Colitis: A Systematic Review and Meta-Analysis. Bénard MV, de Goffau MC, Blonk J, et al. Mediterraneibacter gnavusSegatella copri PubMed ↗
Observational Brazilian journal of microbiology · 2024 Bacteroides fragilis in saliva: investigating links with ulcerative colitis. Zamani S, Besharat S, Behnampour N, et al. Bacteroides fragilis PubMed ↗
Review European journal of gastroenterology & hepatology · 2024 The role of the fecal microbiota in inflammatory bowel disease. Khalaf R, Sciberras M, Ellul P Escherichia coli PubMed ↗
Observational International journal of molecular sciences · 2024 Integrated Analysis of Microbiome and Metabolome Reveals Disease-Specific Profiles in Inflammatory Bowel Diseases and Intestinal Behçet's Disease. Park Y, Ahn JB, Kim DH, et al. Bacteroides fragilis PubMed ↗
Meta-analysis Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024 Gut microbiota-based discovery of Houttuyniae Herba as a novel prebiotic of Bacteroides thetaiotaomicron with anti-colitis activity. Zou LE, Yang YN, Zhan J, et al. Bacteroides thetaiotaomicron PubMed ↗
Observational Wiadomosci lekarskie · 2024 Differentiated approach to management of patients with irritable bowel syndrome and ulcerative colitis in non-alcoholic fatty liver disease. Sirchak YS, Kornash VV, Dutko OO, et al. Escherichia coli PubMed ↗
Observational Nutrients · 2023 Clinical Implications of Dietary Probiotic Supplement (Associated with L-Glutamine and Biotin) in Ulcerative Colitis Patients' Body Composition and Quality of Life. Pavel FM, Bungau SG, Tit DM, et al. Bifidobacterium animalisBifidobacterium longumEnterococcus faecium PubMed ↗
Randomized trial Journal of Crohn's & colitis · 2023 A Mediterranean Diet Pattern Improves Intestinal Inflammation Concomitant with Reshaping of the Bacteriome in Ulcerative Colitis: A Randomised Controlled Trial. Haskey N, Estaki M, Ye J, et al. Alistipes finegoldiiFlavonifractor plautiiRuminococcus bromii PubMed ↗
Review Gastroenterology · 2023 Pathobionts in Inflammatory Bowel Disease: Origins, Underlying Mechanisms, and Implications for Clinical Care. Gilliland A, Chan JJ, De Wolfe TJ, et al. [Clostridium] innocuumPhocaeicola vulgatus PubMed ↗
Review Anaerobe · 2023 Ruminococcus gnavus bacteremia: Literature review and a case report associated with acute flare of ulcerative colitis in an immunocompromised patient. Martínez de Victoria Carazo J, Vinuesa García D, Serrano-Conde Sánchez E, et al. Mediterraneibacter gnavus PubMed ↗
Clinical trial Microbiology spectrum · 2023 Capsulized Fecal Microbiota Transplantation Induces Remission in Patients with Ulcerative Colitis by Gut Microbial Colonization and Metabolite Regulation. Chen Q, Fan Y, Zhang B, et al. Escherichia coliOdoribacter splanchnicus PubMed ↗
Review Digestive diseases · 2023 The Role of Fecal Microbiota Transplantation in the Induction of Remission in Ulcerative Colitis. Saleh A, Parsa S, Garza M, et al. Odoribacter splanchnicus PubMed ↗
Randomized trial Alimentary pharmacology & therapeutics · 2023 Efficacy of 1-kestose supplementation in patients with mild to moderate ulcerative colitis: A randomised, double-blind, placebo-controlled pilot study. Ikegami S, Nakamura M, Honda T, et al. Mediterraneibacter gnavus PubMed ↗